About
Prof. Dr. Herbert Tilg has been clinic director of the University Clinic for Internal Medicine I (Gastroenterology, Hepatology, Endocrinology and Metabolism) at the Medical University of Innsbruck since 2012. He studied medicine at the University of Innsbruck (1980-1986), became a board-certified internist in 1992, and gained additional qualifications in gastroenterology/hepatology (1996), oncology (1997), and intensive care medicine (2001). Research fellowships took him to Tufts University under Charles Dinarello (1991-1993) and to the Université Leuven (1997); from 1994 to 2001 he was lead senior physician at Innsbruck University Hospital's Department of Internal Medicine, and from 2002 he headed internal medicine at Landeskrankenhaus Hall. His research focuses on chronic inflammatory processes and inflammatory mediators (cytokines) in gastroenterology and hepatology, particularly fatty liver disease and inflammatory bowel disease; he has served as associate editor of the journal GUT since 2009. His honors include the Friedrich Wewalka Prize (1992), the Falk Prize (2006), and the Tyrolean State Prize for Science (2021); he was elected to Academia Europaea in 2022 and named a Highly Cited Researcher in 2023.